Showing 15 of 30 articles
Paliperidone is the first medicine to be approved in New Zealand via the expedited ‘Rule of Two’ pathway, says Associate Health Minister David Seymour. “The ‘Rule of Two’ medicines approval pathway was introduced last year. It allows medicines to be approved within 30 days if the product has approval from two recognised overseas jurisdictions,” Mr Seymour says.
Associate Health Minister David Seymour has today welcomed Pharmac’s decision to extend the 12-month transitional access funding limit for Pertuzumab with trastuzumab (Phesgo) for people receiving treatment for certain types of breast cancer in private clinics. “In the past, when Pharmac funded a new cancer treatment, people already paying for that treatment privately are forced to make a very difficult choice: spend their savings to continue private treatment undisrupted, or transfer to a public hospital. The latter can be detrimental to their recovery,” Mr Seymour says.
Pharmac and Health New Zealand are expanding the range of funded medicines community pharmacies can provide without a prescription, including treatments for children’s skin conditions, oral thrush, vaginal thrush, and selected oral contraceptives. This initiative aims to improve timely access to healthcare, especially for rural and remote communities, reduce pressure on the health system, and lower primary care costs for families. Ministers David Seymour and Simeon Brown emphasize that utilizing pharmacists’ skills and pharmacies’ accessibility supports the government’s commitment to delivering quality healthcare close to home.
Regulation Minister David Seymour announced the completion of the Ministry for Regulation’s Product Labelling Review, aiming to ease export and import challenges by updating digital labelling standards and aligning over-the-counter (OTC) medicine labels with Australia. The government will develop a national digital labelling standard to reduce costs and support export growth, while changes to OTC medicine labelling will increase product availability and attract international companies. These reforms are expected to generate significant economic benefits by cutting red tape, lowering compliance costs, and unlocking New Zealand’s economic potential.
Associate Health Minister David Seymour welcomes Pharmac’s decision to expand access to type 2 diabetes medicines based on clinical need, benefiting over 30,000 patients regardless of ethnicity. From 1 September, medicines like empagliflozin and liraglutide will be funded for anyone with high blood sugar despite other treatments, removing previous restrictions related to cardiovascular or renal conditions. This change, supported by community feedback and a new supplier agreement, aims to improve health outcomes, reduce complications, and optimize health budget efficiency.
Associate Health Minister David Seymour has outlined clear expectations for Pharmac to deliver medicines and medical technology efficiently within its fixed budget, emphasizing the need for continued patient-focused processes, improved transparency, and enhanced collaboration with stakeholders. Pharmac has made significant progress by changing its culture, strengthening consumer and supplier partnerships, and improving access to medicines, supported by the Government’s largest-ever budget allocation of $7.2 billion over four years. Despite achievements, including funding decisions benefiting over 680,000 patients, Seymour stresses that ongoing efforts are needed to listen to patients and advance Pharmac’s long-term improvement programme.
The University of Waikato's new medical school, starting in 2028, will train 120 graduate-entry students annually, with clinical placements across five regional areas to encourage doctors to practice in underserved communities. A nationwide distributed clinical placement network is being established to coordinate training across New Zealand’s three medical schools, including new Community Clinical Learning Centres in smaller towns to support rural healthcare workforce growth. This initiative aims to build a stronger, regionally connected health workforce by embedding students in their home regions, addressing long-term shortages in primary care and rural health services.
The University of Waikato's new medical school, starting in 2028, will train 120 graduate-entry students annually with clinical placements across five regional areas to encourage doctors to practice in underserved communities. A new national distributed clinical placement network, developed with Health New Zealand and other universities, will coordinate opportunities and establish Community Clinical Learning Centres in smaller towns to support rural training and retention. This initiative aims to strengthen New Zealand's domestic medical workforce by embedding students in regional and rural settings, addressing long-term shortages, and building a more regionally connected health system.
Associate Health Minister David Seymour supports Pharmac’s new responsibility to fund ambulance medicines from July 1, aiming to provide consistent access to emergency medicines nationwide while achieving cost savings. Following public consultation, Pharmac added seven commonly used ambulance medicines to the funded list to better reflect practical needs and improve patient outcomes. This change integrates ambulance medicines management with hospital medicines, enhancing system efficiency, value for taxpayers, and seamless care transitions between ambulance and hospital services.
Paramedics in New Zealand will be authorized to prescribe certain medicines, enabling more community-based care and reducing pressure on emergency departments, especially benefiting rural and remote areas. This change reflects the evolving role of paramedics beyond emergency response, supported by new training programs and regulatory adjustments under the Medicines Act 1981. The Ministry of Health is consulting on the specific medicines paramedics may prescribe and developing the necessary regulations and scope of practice to implement this policy.
The Government is introducing the Agricultural Compounds and Veterinary Medicines (ACVM) Amendment Bill to streamline access to new agricultural chemicals and veterinary medicines by reducing regulatory complexity and focusing on real risks. The Bill enables reliance on trusted overseas assessments, expedites approval for low-risk products, and works alongside the Hazardous Substances and New Organisms (HSNO) Amendment Bill to create a more adaptive, internationally aligned regulatory framework. These changes aim to enhance safety, trade competitiveness, transparency, and timely decision-making, with the Bill expected to complete parliamentary readings by late 2026.
International Nurses Day highlights the vital role nurses play across New Zealand’s healthcare system, providing skilled, compassionate care in diverse settings from hospitals to rural communities. The government is investing in expanding the nursing workforce through recruitment incentives and advanced training, including support for nurse practitioners who have become essential in delivering advanced clinical care over the past 25 years. Recent legislative changes empower nurse practitioners with expanded prescribing and diagnostic authority, reflecting their integral role in modern, patient-centered healthcare.
The New Zealand Government has introduced a pilot program allowing agri-chemical and veterinary medicine companies to register products in both New Zealand and Australia through a single process, reducing duplication. This streamlined approach maintains safety and effectiveness standards while accelerating approvals, benefiting farmers and veterinarians by providing faster access to new products. The initiative follows a bilateral agreement aimed at enhancing primary sector access to agricultural compounds and veterinary medicines in both countries.
The Government plans to transfer funding responsibility for ambulance medicines from Health New Zealand and ACC to Pharmac to improve procurement efficiency, ensure nationwide access to consistent emergency medicines, and save costs. This change will create a single nationally consistent medicine list for ambulance services, enhancing continuity of care between ambulance providers and hospitals while leveraging Pharmac’s expertise and buying power. Public consultation on the proposal is open from March 12 to April 2, 2024, with implementation targeted for July 1, 2026.
A new coordinated rural hospital medicine and specialist GP training programme has launched on the West Coast to strengthen the home-grown rural health workforce by increasing registrar numbers from two to three to eight to ten. The programme, accredited to deliver Australian College of Rural and Remote Medicine training, offers six to twelve-month placements with strong supervision, support, and aims to retain trainees long-term by fostering community connections. This initiative aligns with the National Rural Health Strategy’s goal of ensuring accessible healthcare for all New Zealanders, particularly those in rural areas.